A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital

systemic lupus erthrematosus is an inflamatory and autoimmune condition characterized by multisystem affection and chronic course with unpredictable flares despite potentially afffecting every oragan . kidney involvment are the most common

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lupus Nephritis Autoimmune Diseases Connective Tissue Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glomerulonephritis Immune System Diseases Kidney Diseases Lupus Erythematosus, Systemic Male Urogenital Diseases Nephritis Skin and Connective Tissue Diseases Urogenital Diseases Urologic Diseases

Age range

1 month–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag university Hospital

Sohag, Egypt

Location status: Recruiting

Location contact

Magdy M Amin, professor

CONTACT

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

aim to include all children fulfilling diagnostic criteria

Exclusion criteria

children with other rheumatological disorder neonates chidren with other nephrolgy disorder

Treatment and study plan

renal biobsy

Diagnostic Test

analsis of renal biobsy and decide grade of renal affection

Other names: abdomial us, laboratory investigation for lupus nephritis

Primary outcomes

remission of LN

Time frame: 1 year

acute on top of chronic
progress to CKD

Time frame: 1 year

affection of kidney become perment

Study contacts

Contact information is provided by the study sponsor or research team.

dr monser M Mohammed, assistant professor

CONTACT

01026372799

randa A ali, resident

CONTACT

[email protected]

01100128936

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Jul 9, 2024
Registry last updated: Jul 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting